Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2002The Journal of ImmunologyOpen Access

CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates

View Full Paper
Ask AI
Bookmark
Share

Authors

DVDaniela VerthelyiCenter for Drug Evaluation and ResearchRKRichard T. KenneyJacksonville UniversityRSRobert A. SederNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Verthelyi et al. (2002) studied this question.

synapsesocial.com/papers/6a20b87dac4c2e2edfeb90d8https://doi.org/10.4049/jimmunol.168.4.1659
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Leishmania amazonensis:The Asian Rhesus Macaques (Macaca mulatta) as an Experimental Model for Study of Cutaneous Leishmaniasis1996 · 36 citations
  2. 2Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells2001 · 883 citations
  3. 3DNA activates human immune cells through a CpG sequence‐dependent manner1999 · 151 citations
  4. 4Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo2000 · 591 citations